Compared to patients in the non-END group, patients in the END group were older and had higher levels of the baseline NIHSS score, SBP, WBC, neutrophil, CRP, TBil, TC, LDL, apoA, CAD, and AF. The gene discussed is CRP; the disease is atrial fibrillation.